Stefan Duensing

10.3k total citations · 2 hit papers
168 papers, 7.6k citations indexed

About

Stefan Duensing is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Stefan Duensing has authored 168 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Molecular Biology, 77 papers in Pulmonary and Respiratory Medicine and 70 papers in Oncology. Recurrent topics in Stefan Duensing's work include Prostate Cancer Treatment and Research (45 papers), Cancer-related Molecular Pathways (38 papers) and Renal cell carcinoma treatment (28 papers). Stefan Duensing is often cited by papers focused on Prostate Cancer Treatment and Research (45 papers), Cancer-related Molecular Pathways (38 papers) and Renal cell carcinoma treatment (28 papers). Stefan Duensing collaborates with scholars based in Germany, United States and China. Stefan Duensing's co-authors include Karl Münger, Anette Duensing, Markus Hohenfellner, Nina Korzeniewski, John R. Basile, Paul F. Lambert, Christopher P. Crum, Boris Hadaschik, Nicole A. Spardy and Siribang-on Piboonniyom and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Stefan Duensing

162 papers receiving 7.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients

2016 441 citations Jan Philipp Radtke, Yanis Tolstov et al. profile →
Multiparametric Magnetic Resonance Imaging (MRI) and MRI–Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen

2016 245 citations Jan Philipp Radtke, Constantin Schwab et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stefan Duensing Germany	46	3.6k	2.5k	2.0k	1.9k	1.3k	168	7.6k
Daisuke Aoki Japan	47	3.6k 1.0×	2.5k 1.0×	1.7k 0.8×	917 0.5×	2.0k 1.6×	440	11.0k
Tesshi Yamada Japan	50	4.3k 1.2×	2.7k 1.1×	529 0.3×	2.0k 1.1×	1.3k 1.0×	141	8.3k
S Hirohashi Japan	51	4.6k 1.3×	2.7k 1.1×	1.0k 0.5×	1.2k 0.6×	1.1k 0.9×	133	8.7k
Raheela Ashfaq United States	58	4.0k 1.1×	3.8k 1.5×	1.2k 0.6×	1.8k 1.0×	1.9k 1.5×	194	10.1k
Alessandro D. Santin United States	53	3.2k 0.9×	4.6k 1.9×	1.1k 0.6×	1.5k 0.8×	1.4k 1.1×	353	10.6k
Bruce A. Woda United States	49	2.8k 0.8×	2.3k 0.9×	826 0.4×	1.8k 1.0×	1.2k 0.9×	181	9.1k
Emmett V. Schmidt United States	51	4.6k 1.3×	3.7k 1.5×	948 0.5×	946 0.5×	1.2k 0.9×	144	9.3k
Fumihiko Kanai Japan	54	4.3k 1.2×	1.8k 0.7×	1.8k 0.9×	587 0.3×	883 0.7×	158	8.7k
Alain C. Mita United States	46	3.7k 1.0×	3.4k 1.4×	731 0.4×	1.8k 1.0×	989 0.8×	210	8.1k
Gunnar B. Kristensen Norway	59	3.6k 1.0×	4.3k 1.7×	1.7k 0.9×	1.7k 0.9×	2.2k 1.7×	266	14.7k

Countries citing papers authored by Stefan Duensing

Since Specialization

Citations

This map shows the geographic impact of Stefan Duensing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Duensing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Duensing more than expected).

Fields of papers citing papers by Stefan Duensing

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Duensing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Duensing. The network helps show where Stefan Duensing may publish in the future.

Co-authorship network of co-authors of Stefan Duensing

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Duensing. A scholar is included among the top collaborators of Stefan Duensing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Duensing. Stefan Duensing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Görtz, Magdalena, et al.. (2023). An artificial intelligence-based chatbot for prostate cancer education: Design and patient evaluation study. Digital Health. 9. 589817016–589817016. 54 indexed citations

Schütz, Viktoria, Huancai Lin, Adam Kaczorowski, et al.. (2023). Long-Term Survival of Patients with Stage T1N0M1 Renal Cell Carcinoma. Cancers. 15(24). 5715–5715. 2 indexed citations

Schwarz, Sebastian, Cathleen Nientiedt, Elena‐Sophie Prigge, et al.. (2023). Senescent Tumor Cells Are Frequently Present at the Invasion Front: Implications for Improving Disease Control in Patients with Locally Advanced Prostate Cancer. Pathobiology. 90(5). 312–321. 4 indexed citations

Sailer, Verena, Gunhild von Amsberg, Stefan Duensing, et al.. (2022). Experimental in vitro, ex vivo and in vivo models in prostate cancer research. Nature Reviews Urology. 20(3). 158–178. 31 indexed citations

Görtz, Magdalena, Joanne Nyarangi‐Dix, Viktoria Schütz, et al.. (2022). Impact of Surgeon’s Experience in Rigid versus Elastic MRI/TRUS-Fusion Biopsy to Detect Significant Prostate Cancer Using Targeted and Systematic Cores. Cancers. 14(4). 886–886. 5 indexed citations

Nyarangi‐Dix, Joanne, et al.. (2021). Evolution of Salvage Radical Prostatectomy from Open to Robotic and Further to Retzius Sparing Surgery. Journal of Clinical Medicine. 11(1). 202–202. 7 indexed citations

Heckmann-Nötzel, Doreen, Adam Kaczorowski, Markus Hohenfellner, et al.. (2021). miR-449a Repression Leads to Enhanced NOTCH Signaling in TMPRSS2:ERG Fusion Positive Prostate Cancer Cells. Cancers. 13(5). 964–964. 8 indexed citations

Heckmann, Doreen, et al.. (2020). The ERG-Regulated LINC00920 Promotes Prostate Cancer Cell Survival via the 14-3-3ϵ–FOXO Pathway. Molecular Cancer Research. 18(10). 1545–1559. 12 indexed citations

Rempel, Eugen, Volker Endris, Michael Allgäuer, et al.. (2020). Immuno‐oncology gene expression profiling of formalin‐fixed and paraffin‐embedded clear cell renal cell carcinoma: Performance comparison of theNanoString nCountertechnology with targetedRNAsequencing. Genes Chromosomes and Cancer. 59(7). 406–416. 9 indexed citations

10.

Bernemann, Christof, Julie Steinestel, Xin Chen, et al.. (2019). Comparative Analysis of AR Variant AR-V567es mRNA Detection Systems Reveals Eminent Variability and Questions the Role as a Clinical Biomarker in Prostate Cancer. Clinical Cancer Research. 25(13). 3856–3864. 15 indexed citations

11.

Korzeniewski, Nina, Samuel Peña‐Llopis, Claudia Scholl, et al.. (2019). Cullin 5 is a novel candidate tumor suppressor in renal cell carcinoma involved in the maintenance of genome stability. Oncogenesis. 8(1). 4–4. 11 indexed citations

12.

Queisser, Angela, et al.. (2014). Comparison of different prostatic markers in lymph node and distant metastases of prostate cancer. Modern Pathology. 28(1). 138–145. 45 indexed citations

13.

Cuevas, Rolando, Nina Korzeniewski, Yanis Tolstov, Markus Hohenfellner, & Stefan Duensing. (2012). FGF-2 Disrupts Mitotic Stability in Prostate Cancer through the Intracellular Trafficking Protein CEP57. Cancer Research. 73(4). 1400–1410. 19 indexed citations

14.

Park, Jung Wook, Henry C. Pitot, Katerina Strati, et al.. (2010). Deficiencies in the Fanconi Anemia DNA Damage Response Pathway Increase Sensitivity to HPV-Associated Head and Neck Cancer. Cancer Research. 70(23). 9959–9968. 67 indexed citations

15.

Bauer, Sebastian, Joshua A. Parry, Thomas Mühlenberg, et al.. (2009). Proapoptotic Activity of Bortezomib in Gastrointestinal Stromal Tumor Cells. Cancer Research. 70(1). 150–159. 34 indexed citations

16.

Korzeniewski, Nina, Léon Zheng, Rolando Cuevas, et al.. (2009). Cullin 1 Functions as a Centrosomal Suppressor of Centriole Multiplication by Regulating Polo-like Kinase 4 Protein Levels. Cancer Research. 69(16). 6668–6675. 47 indexed citations

17.

Spardy, Nicole A., et al.. (2009). Human Papillomavirus 16 E7 Oncoprotein Attenuates DNA Damage Checkpoint Control by Increasing the Proteolytic Turnover of Claspin. Cancer Research. 69(17). 7022–7029. 74 indexed citations

18.

Duensing, Anette, Nicole A. Spardy, Payel Chatterjee, et al.. (2009). Centrosome overduplication, chromosomal instability, and human papillomavirus oncoproteins. Environmental and Molecular Mutagenesis. 50(8). 741–747. 44 indexed citations

19.

Liu, Ying, Michelle Tseng, Ferdinand Rossi, et al.. (2007). Histone H2AX Is a Mediator of Gastrointestinal Stromal Tumor Cell Apoptosis following Treatment with Imatinib Mesylate. Cancer Research. 67(6). 2685–2692. 73 indexed citations

20.

Duensing, Stefan, et al.. (1998). Loss of VLA-3 (CD49c/CD29) Expression in Two Multidrug Resistant Burkitt's Lymphoma Cell Lines. Cancer Biotherapy and Radiopharmaceuticals. 13(5). 369–373. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact